|
Nalbuphine HclDrug - Nalbuphine Hcl The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Nalbuphine Hydrochloride
Strength -
1.5MG/ML
Applicant -
ABBOTT
New Drug Application (NDA) Number -
020200
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Mar 12, 1993
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Abbott Laboratories
Nalbuphine Hcl
Unipen Eq 4gm Base/vial Injectable; Injection
Unipen Eq 500mg Base/vial Injectable; Injection Unipen Eq 500mg Base/vial Injectable; Injection Unipen In Plastic Container Eq 1gm Base/vial Injectable; Injection Unipen Eq 500mg Base Tablet; Oral Naftin 1% Cream; Topical Naftin 1% Gel; Topical Nalbuphine 10mg/ml Injectable; Injection Nalbuphine 20mg/ml Injectable; Injection Nalbuphine Hcl 1.5mg/ml Injectable; Injection NewDrugInformation |